TransEnterix, Inc. TRXC, +4.13% a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today announced that it has received Japanese regulatory approval for the Senhance™ Surgical System.
“Regulatory approval in Japan is a pivotal milestone for our company, as Japan is second only to the U.S....
To many investors that are holding bags TRXC is garbage. But at the time those individuals purchased those shares they bought in to a start up surgical robotic company with rising potential and patented technology. The chart to some may look painful and deflating, stomach turning, but to the right kind of eyes the algos point towards a progressive future. TRXC...
Note: This is not an investment advice but my opinion alone. Please feel free to comment.
TRXC has been on a downtrend since its recent high. I think the downside may not be done as it completes its correction. Looking at the FIB ratio (.786), I see it reaching $1.89 which will also fill the gap it created on May 9th 2018 (when looking at the daily chart).
Using advanced indicators that I have developed and use, you don't want to stick your face to the computer 24/7 and using the bad or good feeling winning or losing it all. It is about using indicators and identifying when to enter (buy) and when to leave (sell). You don't need the +100% jackpot gainer. Over 10 days a +10% win in a row gives you +159% gain. Using...
I've been waiting for some time now to see TRXC re-establish it's uptrend. I've posted prior ideas that have not come to fruition. If you are looking to take a long position on TRXC, I think the following indications will confirm an entry point for you in the next couple of days.
BUY SIGNALS:
1) 7-day JMA crossing up on 10-day DWMA: If you backtest this...
On my last TRXC post, I whiffed on my prediction that we'd probably see the rebound begin late last week. The difference appears to be the result of bond yields' effect on the overall market, which particularly impacted the stocks that have been most bullish this year. Our charts and positions don't exist in a vacuum, and this served as a reminder that we have...
TRXC had a nice rebound last week but ran too far, too fast, and stumbled again. Silver lining, the the 0.618 fib level on my chart held up perfectly. I was able to buy the dip @ 5.17. Looking at my indicators, I think we have another day or two of mostly trading between .5 and .618 fib levels. Expect another stop-loss raid and at least a brief moment of...
Industry:Medical Equipment, Supplies & Distribution
Employees:174
TransEnterix, Inc. is a medical device company. The Company is focused on the development and commercialization of ALF-X Surgical Robotic System (the ALF-X System), and SurgiBot System. The Company's ALF-X System is a multi-port robotic surgery system, which allows multiple robotic arms to control instruments and a camera. The system features advanced technology to enable surgeons with haptic feedback and the ability to move the camera through eye movement. The system replicates laparoscopic motion and integrates three-dimensional high definition (3DHD) vision technology. The ALF-X System also offers responsible economics to hospitals by offering robotic technology with reusable instruments. The SurgiBot System is designed as a single-incision, patient-side robotic-assisted surgery system. The Company also develops and manufactures laparoscopic surgical instruments that are used in abdominal surgery, such as scissors, graspers, clip appliers, and suction and irrigation instruments.
This website uses cookies to ensure you get the best experience on our website. To learn more about cookies, including how to control cookies, please read our Cookies Policy.
TRXC
